| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.31 | 0.03 |